Joseph LaRosa
EVP General Counsel and Secret at Regeneron Pharmaceuticals. Based in Tarrytown, New York.
- Rank
- 2766th of 14,644
- Companies held
- 1
- Largest holding
- REGN, 100.0% of total
- Latest SEC filing
- Nov 2, 2026
What the $44.4M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Regeneron Pharmaceuticals REGN Common Stock | Directly | 38,906 | $923.34 | $35.9M | 80.8% | Form 4, Nov 2, 2026 |
| Regeneron Pharmaceuticals REGN Common Stock | Through 2025 GRAT | 5,407 | $923.34 | $5.0M | 11.2% | Form 4, Nov 2, 2026 |
| Regeneron Pharmaceuticals REGN Common Stock | Through 2024 GRAT | 3,402 | $923.34 | $3.1M | 7.1% | Form 4, Aug 19, 2026 |
| Regeneron Pharmaceuticals REGN Common Stock | Through 401(k) Plan | 413 | $923.34 | $381K | 0.9% | Form 4, Nov 2, 2026 |
Share counts are the amounts Joseph LaRosa reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 2763 | James A. Lico President and CEO, Fortive. Boston, MA | $44.5M |
| 2764 | Parag Mallick Chief Scientist, Nautilus Biotechnology. Seattle, WA | $44.5M |
| 2765 | Steven F. Urvan Chief Executive Officer, Outdoor Holding. Boca Raton, FL | $44.5M |
| 2766 | Joseph LaRosa EVP General Counsel and Secret, Regeneron Pharmaceuticals. Tarrytown, NY | $44.4M |
| 2767 | Robert P. Rooney Head of Tech/Ops/Resilience, Morgan Stanley. New York, NY | $44.4M |
| 2768 | Cory Giese Director, TriCo Bancshares. Chico, CA | $44.4M |
| 2769 | Martin P. Waters CEO, Victorias Secret &. Reynoldsburg, OH | $44.4M |
Other Regeneron Pharmaceuticals insiders
All REGN insiders- Leonard S. Schleifer$2.21BBd. Co-Chair, President & CEO. #141 overall
- George Yancopoulos$855MBd. Co-Chair, President & CSO. #312 overall
- P. Roy Vagelos$431MDirector. #529 overall
- Neil E. Stahl$54.7MEVP Research and Development. #2374 overall
- Andrew Murphy$47.3MCo-Chief Scientific Officer. #2647 overall
- Daniel P. Van Plew$32.5MEVP & General Mgr, Industrial. #3541 overall
Questions
How much stock does Joseph LaRosa own?
Joseph LaRosa holds $44,438,508 in listed stock based on SEC filings and current prices, mostly Regeneron Pharmaceuticals (REGN). That ranks 2766th on the Stock Rich List.
Is this Joseph LaRosa's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Joseph LaRosa last buy or sell stock?
The most recent open-market trade on file is a sale of 3,939 REGN shares on Nov 2, 2026 at $965.41.